Atlas Trials

An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.

Clinical trial NCT00240838 · COMPLETED

Trial details

NCT number
NCT00240838
Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pain
Start date
2003-05-01
Enrollment
483

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.